CJC-1295 without DAC + Ipamorelin Blend

CJC-1295 without DAC + Ipamorelin – Synergistic GH Research Peptide Blend

The CJC-1295 without DAC + Ipamorelin Blend is a combined
research peptide formulation designed to study the
stimulation of growth hormone (GH) release through multiple
complementary mechanisms. This blend combines
CJC-1295 without DAC, a GHRH analogue that supports the
physiological pulsatile release of growth hormone, with Ipamorelin,
a GHRP that acts on the ghrelin receptor (GHSR),
creating a synergistic research model.

This peptide combination is manufactured according to high laboratory standards
and verified using High-Performance Liquid Chromatography (HPLC) to ensure
a purity of ≥ 99%. The blend is supplied exclusively for controlled
endocrinological and biochemical research under in-vitro conditions.

Blend composition

• CJC-1295 without DAC – 5 mg:
  Studied for its role in supporting the natural pulsatile release of
  growth hormone via the GHRH receptor.
• Ipamorelin – 5 mg:
  Investigated for its selective activation of the
  ghrelin receptor (GHSR), without significant interaction with
  cortisol or prolactin pathways in research models.

Key specifications

Application & use (research only)

• Intended exclusively for in-vitro research purposes.
• Not suitable for human or veterinary consumption or medical use.
• Applicable to endocrinological research on growth hormone regulation and ghrelin receptor activity.
• Lyophilized form supports stable storage and controlled laboratory handling.